SMTL ID : 8bo7.1

COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE INHIBITOR 34

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.25 Å
Oligo State
monomer
Ligands
1 x QW6: 4-[[(2~{S})-2-[4-(5-chloranyl-2-cyano-phenyl)-3-methoxy-6-oxidanylidene-2,5-dihydropyridin-1-yl]-3-[(2~{S})-oxan-2-yl]propanoyl]amino]benzoic acid(Non-covalent)
1 x CIT: CITRIC ACID(Non-functional Binders)
1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Roehrig, S. et al., Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. J.Med.Chem. (2023)
Release Date
2023-09-13
Peptides
Coagulation factor XIa light chain: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
AAA

Coagulation factor XIa light chain

Related Entries With Identical Sequence

3sor.1 | 3sos.1 | 4x6p.1 | 4x6p.2 | 5exn.1 | 6hhc.1 | 6r8x.1 | 6ts5.1 | 6ts6.1 | 6ts7.1 | 6usy.1 | 6vlu.1 | 6vlv.1 | 7mbo.1 | 7v0z.1 | 7v10.1 | 7v11.1 | 7v12.1 | 7v13.1 | 7v14.1 | 7v15.1 | 7v16.1 | 7v17.1 | 7v18.1 | 8bo3.1 | 8bo4.1 | 8bo5.1 | 8bo6.1